Vortioxetine: a review of efficacy, safety and tolerability with a focus on cognitive symptoms in major depressive disorder
Author:
Publisher
Informa Healthcare
Subject
Pharmacology (medical),General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/14740338.2015.1046836
Reference50 articles.
1. Differentiating antidepressants of the future: Efficacy and safety
2. Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunction
3. Pharmacokinetic Drug Interactions Involving Vortioxetine (Lu AA21004), a Multimodal Antidepressant
Cited by 55 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Vortioxetine improved schizophrenia‐like behavioral deficits in a Poly I:C‐induced maternal immune activation model of schizophrenia in rats;Fundamental & Clinical Pharmacology;2024-07-04
2. Individualized strategies for depression: narrative review of clinical profiles responsive to vortioxetine;Annals of General Psychiatry;2024-05-16
3. Evaluating an EEG-based tool for assessing acute clinical and cognitive changes in adult outpatients with MDD treated with open-label, flexible-dose vortioxetine: A pilot study;Journal of Affective Disorders Reports;2024-04
4. Effects of Vortioxetine on Cognition and Fatigue in Patients with Multiple Sclerosis and Depression: A Case Series Study;CNS & Neurological Disorders - Drug Targets;2024-03
5. Adherence to Antidepressants in Korean Elderly Patients with Major Depressive Disorder;Korean Journal of Clinical Pharmacy;2023-03-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3